BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
In a rare occurrence worldwide, the CK Birla Hospital® treats 32-year-old woman for a giant mesenteric tumour via complex laparoscopic surgery
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
Subscribe To Our Newsletter & Stay Updated